Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathwayVasanthi S. Viswanathan, Stuart L. Schreiber, Matthew J. Ryan et al.|Nature|2017Cited by 2k
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinomaZiad Bakouny, Srinivas R. Viswanathan, Natalie I. Vokes et al.|Nature Communications|2021Cited by 167
Integrative clinical and molecular characterization of translocation renal cell carcinomaZiad Bakouny, Srinivas R. Viswanathan, Ananthan Sadagopan et al.|Cell Reports|2022Cited by 115
TFE3 fusions direct an oncogenic transcriptional program that drives OXPHOS and unveils vulnerabilities in translocation renal cell carcinomaJiao Li, Srinivas R. Viswanathan|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 6
Phenotypic screening converges on CDK9 inhibition as a therapeutic strategy in translocation renal cell carcinomaDharma R. Thapa, Srinivas R. Viswanathan|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1